-
Could rewiring the brain’s “brakes” improve movement in Huntington’s disease?
6 min read
Latest News
-
Meet the enemy: neutron ray reveals HD protein structure
5 min read
Scientists use beams of neutrons to study the structure of clumps of mutant huntingtin protein
-
'Floating' gene-silencing drugs into the brain with exosomes
6 min read
Exosomes – tiny bubbles made by cells – could be used to get gene silencing drugs from the bloodstream into the brain
-
Improving Huntington's disease clinical trial recruitment through patient and family education
5 min read
How can we improve recruitment into Huntington's disease clinical trials? Talking directly with families works!
-
Chubby mice reveal the importance of the hypothalamus in Huntington's disease
6 min read
Huntington's disease mice are fat but HD patients lose weight – is a brain area called the hypothalamus to blame?
-
The genetic 'gray area' of Huntington's disease: what does it all mean?
8 min read
Intermediate alleles and reduced penetrance – the genetic 'gray area' of Huntington’s disease, explained
-
Dimebon fails in late-stage human HD clinical trial
3 min read
Dimebon fails to improve symptoms in HD patients in the HORIZON trial
-
FDA: further trial needed for Huntexil approval in HD
2 min read
Bad news for Huntexil – the FDA requires another trial before it can be approved in the US
-
Successful gene therapy trial in Parkinson’s Disease gives hope for HD
5 min read
Success for brain ‘gene therapy’ in Parkinson’s disease – good news for similar treatments being developed in HD
-
Gene silencing for HD: the story so far
10 min read
Is gene silencing as exciting as it sounds for HD, and what might the future hold?
-
Interview: Graeme Bilbe, Global Head for Neuroscience at Novartis
7 min read
HDBuzz interviews Graeme Bilbe, Global Head for Neuroscience at pharmaceutical giant Novartis, about their HD researc
HDBuzz Trial Tracker
Show 8 more Show less
Updates from the ongoing Phase 3 INVEST-HD trial of votoplam
Updates from the Phase 1b/2a REGEN4HD trial of neural stem cell therapy hNSC-01
Updates from the ongoing Phase 2/3 FALCON-HD trial of SKY-0515
